MediK8 launches the Exo-PDRN Pristmatic+ Serum, a concentrated formula combining two of skincare's most talked-about actives. Exosomes, cell-derived vesicles that deliver biological signals to skin, pair with PDRN (polydeoxyribonucleotide), a marine-derived ingredient proven to stimulate collagen production and improve skin texture.

The serum targets fine lines, dullness, and uneven tone. PDRN works by activating fibroblasts and increasing hyaluronic acid synthesis, while exosomes penetrate deeper layers to support cellular renewal. The formula delivers both immediate hydration and longer-term structural improvements.

MediK8 positions this product at the intersection of dermatological science and luxury skincare. The brand uses pharmaceutical-grade PDRN sourced from salmon sperm and proprietary exosome technology. The Pristmatic+ version includes light-reflecting minerals that provide an instant glow while active ingredients work beneath the surface.

This launch reflects the broader industry shift toward biomimetic and regenerative skincare. Exosomes remain expensive to produce, keeping this product in premium territory. The dual-action formula appeals to consumers willing to invest in clinical-grade solutions that combine visible results with cellular benefits.